Literature DB >> 22752116

GADD45γ regulates TNF-α and IL-6 synthesis in THP-1 cells.

Gyu-Tae Shin1, Hwa Joung Lee, Heungsoo Kim.   

Abstract

OBJECTIVE AND
DESIGN: This study investigated the link between growth arrest and DNA damage 45γ (GADD45γ) expression and tumor necrosis factor-α (TNF-α) and interleukin-6 (IL-6) synthesis.
METHODS: We stimulated THP-1 monocyte cells using lipopolysaccharide (LPS). We knocked-down and over-expressed GADD45γ using lentiviral vectors harboring GADD45γ short hairpin RNA and GADD45γ open reading frame, respectively. To inhibit activation of c-Jun-terminal kinase (JNK), we used a specific inhibitor, SP600125.
RESULTS: LPS stimulation of THP-1 cells resulted in increased expression of GADD45γ mRNA which reached its peak 2 h after stimulation and gradually diminished thereafter. TNF-α and IL-6 were up-regulated at both the mRNA and protein levels in activated THP-1 cells. Knock-down of GADD45γ reduced TNF-α protein production by up to 75 % and IL-6 protein by up to 60 %. In contrast, over-expression of GADD45γ increased TNF-α production by six-fold and IL-6 protein by 80-fold. There was a discrepancy between TNF-α mRNA and its protein level, whereas IL-6 mRNA and its protein level were correlated. Knock-down of GADD45γ decreased the JNK activity, suggesting that JNK may play the role of a downstream mediator for the pro-inflammatory effects of GADD45γ.
CONCLUSIONS: We show evidence that GADD45γ may regulate TNF-α and IL-6 expression in activated THP-1 monocyte cells.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22752116     DOI: 10.1007/s00011-012-0515-x

Source DB:  PubMed          Journal:  Inflamm Res        ISSN: 1023-3830            Impact factor:   4.575


  32 in total

1.  Human immunodeficiency virus type 1 spinoculation enhances infection through virus binding.

Authors:  U O'Doherty; W J Swiggard; M H Malim
Journal:  J Virol       Date:  2000-11       Impact factor: 5.103

2.  Chloroquine inhibits production of TNF-alpha, IL-1beta and IL-6 from lipopolysaccharide-stimulated human monocytes/macrophages by different modes.

Authors:  C-H Jang; J-H Choi; M-S Byun; D-M Jue
Journal:  Rheumatology (Oxford)       Date:  2006-01-17       Impact factor: 7.580

3.  A role for TNF-alpha and mucosal T helper-1 cytokines in the pathogenesis of Crohn's disease.

Authors:  S E Plevy; C J Landers; J Prehn; N M Carramanzana; R L Deem; D Shealy; S R Targan
Journal:  J Immunol       Date:  1997-12-15       Impact factor: 5.422

4.  DNA damage-inducible transcripts in mammalian cells.

Authors:  A J Fornace; I Alamo; M C Hollander
Journal:  Proc Natl Acad Sci U S A       Date:  1988-12       Impact factor: 11.205

5.  Etanercept therapy in rheumatoid arthritis. A randomized, controlled trial.

Authors:  L W Moreland; M H Schiff; S W Baumgartner; E A Tindall; R M Fleischmann; K J Bulpitt; A L Weaver; E C Keystone; D E Furst; P J Mease; E M Ruderman; D A Horwitz; D G Arkfeld; L Garrison; D J Burge; C M Blosch; M L Lange; N D McDonnell; M E Weinblatt
Journal:  Ann Intern Med       Date:  1999-03-16       Impact factor: 25.391

Review 6.  Interleukin 6 and its receptor: ten years later.

Authors:  T Hirano
Journal:  Int Rev Immunol       Date:  1998       Impact factor: 5.311

7.  Tumour necrosis factor in serum and synovial fluid of patients with active and severe rheumatoid arthritis.

Authors:  C Tetta; G Camussi; V Modena; C Di Vittorio; C Baglioni
Journal:  Ann Rheum Dis       Date:  1990-09       Impact factor: 19.103

8.  A family of stress-inducible GADD45-like proteins mediate activation of the stress-responsive MTK1/MEKK4 MAPKKK.

Authors:  M Takekawa; H Saito
Journal:  Cell       Date:  1998-11-13       Impact factor: 41.582

9.  Effect of interleukin-6 receptor inhibition with tocilizumab in patients with rheumatoid arthritis (OPTION study): a double-blind, placebo-controlled, randomised trial.

Authors:  Josef S Smolen; Andre Beaulieu; Andrea Rubbert-Roth; Cesar Ramos-Remus; Josef Rovensky; Emma Alecock; Thasia Woodworth; Rieke Alten
Journal:  Lancet       Date:  2008-03-22       Impact factor: 79.321

10.  Human anti-tumor necrosis factor monoclonal antibody (adalimumab) in Crohn's disease: the CLASSIC-I trial.

Authors:  Stephen B Hanauer; William J Sandborn; Paul Rutgeerts; Richard N Fedorak; Milan Lukas; Donald MacIntosh; Remo Panaccione; Douglas Wolf; Paul Pollack
Journal:  Gastroenterology       Date:  2006-02       Impact factor: 22.682

View more
  4 in total

1.  GADD45G Interacts with E-cadherin to Suppress the Migration and Invasion of Esophageal Squamous Cell Carcinoma.

Authors:  Tongtong Li; Lele Xu; Jinglei Teng; Yunping Ma; Wenzhong Liu; Yan Wang; Xinming Chi; Shujuan Shao; Yan Dong; Qimin Zhan; Xuefeng Liu
Journal:  Dig Dis Sci       Date:  2019-09-27       Impact factor: 3.199

2.  A Mouse Brain-based Multi-omics Integrative Approach Reveals Potential Blood Biomarkers for Ischemic Stroke.

Authors:  Alba Simats; Laura Ramiro; Teresa García-Berrocoso; Ferran Briansó; Ricardo Gonzalo; Luna Martín; Anna Sabé; Natalia Gill; Anna Penalba; Nuria Colomé; Alex Sánchez; Francesc Canals; Alejandro Bustamante; Anna Rosell; Joan Montaner
Journal:  Mol Cell Proteomics       Date:  2020-08-31       Impact factor: 5.911

3.  ATF4 is directly recruited by TLR4 signaling and positively regulates TLR4-trigged cytokine production in human monocytes.

Authors:  Chunyan Zhang; Nan Bai; Antao Chang; Zhuhong Zhang; Jing Yin; Wenzhi Shen; Yaping Tian; Rong Xiang; Chenghu Liu
Journal:  Cell Mol Immunol       Date:  2012-12-17       Impact factor: 11.530

4.  Carcinoembryonic antigen as a marker of radioresistance in colorectal cancer: a potential role of macrophages.

Authors:  Eng-Yen Huang; Jen-Chieh Chang; Hong-Hwa Chen; Chieh-Ying Hsu; Hsuan-Chih Hsu; Keng-Liang Wu
Journal:  BMC Cancer       Date:  2018-03-27       Impact factor: 4.430

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.